Literature DB >> 15585320

Post-translational control of chemokines: a role for decoy receptors?

Iain Comerford1, Robert J B Nibbs.   

Abstract

It is well-established that chemokines play a critical role in the orchestration of inflammation and immunity. Interactions between chemokines and their receptors are essential for the homing of specific subsets of leukocytes to their functional microenvironments. They also influence other diverse biological processes such as development, leukocyte activation, Th1/Th2 polarisation, tumour metastasis, angiogenesis, and HIV pathogenesis. However, despite their importance, only now are we beginning to understand the complex regulation brought to bear on these molecules. In this review, we discuss a number of these key chemokine regulators that exert their influence once these proteins have been synthesised. We examine (i) chemokine storage, release, and presentation, (ii) protease regulation, (iii) viral manipulation of host chemokines, and (iv) natural mammalian receptor antagonists. Principally, the growing evidence for a role for decoy receptors in the chemokine system is discussed. In particular, the potential decoy function of the 'silent' pro-inflammatory chemokine receptor D6 is described alongside two other candidate decoy receptor molecules, DARC, and CCX-CKR. Dissecting the biological and pathological function of these chemokine controllers will lead to a deeper understanding of chemokine regulation, and may reveal novel strategies to therapeutically modify the chemokine system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15585320     DOI: 10.1016/j.imlet.2004.08.018

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  19 in total

1.  A recombinant dromedary antibody fragment (VHH or nanobody) directed against human Duffy antigen receptor for chemokines.

Authors:  Dorota Smolarek; Claude Hattab; Gholamreza Hassanzadeh-Ghassabeh; Sylvie Cochet; Carlos Gutiérrez; Alexandre G de Brevern; Rachanee Udomsangpetch; Julien Picot; Magdalena Grodecka; Kazimiera Wasniowska; Serge Muyldermans; Yves Colin; Caroline Le Van Kim; Marcin Czerwinski; Olivier Bertrand
Journal:  Cell Mol Life Sci       Date:  2010-05-11       Impact factor: 9.261

Review 2.  The chemokine network. I. How the genomic organization of chemokines contains clues for deciphering their functional complexity.

Authors:  R Colobran; R Pujol-Borrell; M P Armengol; M Juan
Journal:  Clin Exp Immunol       Date:  2007-05       Impact factor: 4.330

3.  Monocyte chemoattractant protein 1, macrophage inflammatory protein 1 alpha, and RANTES recruit macrophages to the kidney in a mouse model of hemolytic-uremic syndrome.

Authors:  Tiffany R Keepers; Lisa K Gross; Tom G Obrig
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

4.  Shedding light on DARC: the role of the Duffy antigen/receptor for chemokines in inflammation, infection and malignancy.

Authors:  K Horne; Ian J Woolley
Journal:  Inflamm Res       Date:  2009-03-17       Impact factor: 4.575

Review 5.  In silico studies on DARC.

Authors:  Alexandre G de Brevern; Ludovic Autin; Yves Colin; Olivier Bertrand; Catherine Etchebest
Journal:  Infect Disord Drug Targets       Date:  2009-06

Review 6.  Chemokine receptor internalization and intracellular trafficking.

Authors:  Nicole F Neel; Evemie Schutyser; Jiqing Sai; Guo-Huang Fan; Ann Richmond
Journal:  Cytokine Growth Factor Rev       Date:  2005-07-05       Impact factor: 7.638

Review 7.  Erythrocyte Duffy antigen receptor for chemokines (DARC): diagnostic and therapeutic implications in atherosclerotic cardiovascular disease.

Authors:  Stavros Apostolakis; Georgios K Chalikias; Dimitrios N Tziakas; Stavros Konstantinides
Journal:  Acta Pharmacol Sin       Date:  2011-03-28       Impact factor: 6.150

8.  A combination of in vitro techniques for efficient discovery of functional monoclonal antibodies against human CXC chemokine receptor-2 (CXCR2).

Authors:  Ronald S Boshuizen; Catherine Marsden; Johan Turkstra; Christine J Rossant; Jerry Slootstra; Clive Copley; Klaus Schwamborn
Journal:  MAbs       Date:  2014       Impact factor: 5.857

9.  Anti-inflammatory therapy by intravenous delivery of non-heparan sulfate-binding CXCL12.

Authors:  Graeme O'Boyle; Paul Mellor; John A Kirby; Simi Ali
Journal:  FASEB J       Date:  2009-08-10       Impact factor: 5.191

10.  Early immune response following Salmonella enterica subspecies enterica serovar Typhimurium infection in porcine jejunal gut loops.

Authors:  François Meurens; Mustapha Berri; Gael Auray; Sandrine Melo; Benoît Levast; Isabelle Virlogeux-Payant; Claire Chevaleyre; Volker Gerdts; Henri Salmon
Journal:  Vet Res       Date:  2008-10-16       Impact factor: 3.683

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.